Staphylococcal Skin Infections

Also known as: Staphylococcal Skin Infection / Staphylococcal skin disorder

DrugDrug NameDrug Description
DB00833CefaclorSemisynthetic, broad-spectrum antibiotic derivative of cephalexin.
DB00199ErythromycinErythromycin is an antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the _macrolide_ group of antibiotics [FDA label]. It was originally discovered in 1952. Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive bacteria, gram-negative bacteria and many other organisms [L5245], [FDA label].